159TiP COPERNIC: A study of on-treatment circulating tumour (ct)DNA changes in chemo-refractory colorectal cancer (CRC) patients.

MLA

Assaf, I., et al. “159TiP COPERNIC: A Study of on-Treatment Circulating Tumour (Ct)DNA Changes in Chemo-Refractory Colorectal Cancer (CRC) Patients.” Annals of Oncology, vol. 35, June 2024, pp. S70–71. EBSCOhost, https://doi.org/10.1016/j.annonc.2024.05.169.

APA

Assaf, I., Bregni, G., Anthoine, G., Aparicio, T., Artru, P., Ben Abdelghani, M., Chibaudel, B., Coart, E., Diaz, M., Evrard, C., Geboes, K., Ghiringhelli, F., Puleo, F., Raimbourg, J., Vandamme, T., van den Eynde, M., Hendlisz, A., & Sclafani, F. (2024). 159TiP COPERNIC: A study of on-treatment circulating tumour (ct)DNA changes in chemo-refractory colorectal cancer (CRC) patients. Annals of Oncology, 35, S70–S71. https://doi.org/10.1016/j.annonc.2024.05.169

Chicago

Assaf, I., G. Bregni, G. Anthoine, T. Aparicio, P. Artru, M. Ben Abdelghani, B. Chibaudel, et al. 2024. “159TiP COPERNIC: A Study of on-Treatment Circulating Tumour (Ct)DNA Changes in Chemo-Refractory Colorectal Cancer (CRC) Patients.” Annals of Oncology 35 (June): S70–71. doi:10.1016/j.annonc.2024.05.169.